Skip to main content

Table 2 Anthropometric and clinical data of patients obtaining more than 8 oocytes at ovum pick-up. Women in Group A received r-FSH + r-LH/2:1, those in Group B hMG. Data are expressed as mean ± SD or as percentage

From: Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population

 

Group A

Group B

p

Number of patients

101

109

 

Age (yrs)

36.2 ± 4.3

35.7 ± 4.5

ns

Basal (day 3) FSH (IU/l)

7.1 ± 2.5

7.2 ± 2.8

ns

BMI

22.7 ± 3.9

22.3 ± 2.9

ns

Main infertility cause (%)

  

ns

Anovulation

0

0.9 %

 

Endometriosis

8.9

8.3

 

Male

43.6

43.1

 

Tubal

11.9

18.3

 

Unexplained

24.7

23.8

 

Mixed

10.9

5.5

 

Smokehabit (%)

14.8

20.2

ns

Total Gonadotropin dose (IU)

2453 ± 1539

2801 ± 1117

ns

Peak E2 (pg/ml)

2924 ± 1175

2649 ± 964

ns

Retrieved oocytes/patient

12.4 ± 3.6

11.9 ± 3.3

ns

MII oocytes/patient

9.2 ± 2.4

9.1 ± 2.3

ns

Embryo morphological score

7.1 ± 2.8

6.9 ± 3.0

ns

Top scored (>8/10) embryos (%)

28

25

ns

Number of transferred embryos

2.3 ± 0.7

2.4 ± 0.7

ns

Endometrial thickness (mm)

10.6 ± 2.5

10.8 ± 2.2

ns